CRANBURY, N.J.--(BUSINESS WIRE)--Innophos Holdings, Inc. (NASDAQ:IPHS), a leading international producer of essential ingredients, today announced that it is expanding its portfolio of co-processed, ...
“Due to the multi-component nature of excipients, what drives excipient performance depends on its intended application,” Karry observes. For example, she notes that a co-processed excipient may ...
Increasing Use of Co-Processed Excipients. Patent Cliffs Driving the Demand for Sugar Excipients in the Generics Market. Increasing Development of Orally Disintegrating Tablets (ODTS). According to ...
“This approach reduces significantly the number of excipients necessary to achieve excellent processability and performance and requires a single dry blending with the API using standard process ...
A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...
DUBLIN, March 23, 2021 /PRNewswire/ -- The "Pharmaceutical Excipients Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product; Functionality; Type of Formulation and Geography" report ...
The pharmaceutical excipients market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the increasing demand for innovative drug formulations, the rising prevalence of chronic diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results